Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Adv Drug Deliv Rev. 2015 Nov 27;99(Pt A):70–84. doi: 10.1016/j.addr.2015.11.015

Figure 3.

Figure 3

Schematic illustration of the formation of drug-loaded hypoxia-responsive nanoparticles and in vivo tumor-targeting pathways. Adapted with permission from Ref. [49].